Open AccessA leopard can’t change its spots: can a T790M mutation-positive cancer change its spots after epidermal growth factor receptor-tyrosine kinase inhibitor therapy?
Author(s) -
Kai Obayashi,
Kimihiro Shimizu,
Seshiru Nakazawa,
Yoichi Ohtaki,
Natsuko Kawatani,
Takashi Ibe,
Toshiki Yajima,
Akira Mogi,
Ken Shirabe
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.10.53
Subject(s) - t790m , epidermal growth factor receptor , medicine , cancer research , tyrosine kinase , tyrosine kinase inhibitor , mutation , lung cancer , oncology , cancer , gefitinib , receptor , biology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom